Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Status:
Recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and exploratory
dose response of paltusotine treatment in subjects with carcinoid syndrome. This study
consists of a Randomized Treatment Phase followed by an Open-Label Extension (OLE) Phase.